OAM
TRPX

Oxford Asset Management’s Therapix Biosciences Ltd. TRPX Stock Holding History

Oxford Asset Management’s Portfolio TRPX Stock Details TRPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-10,709
Closed -$35K – 2151
2018
Q4 		$35K Buy
+10,709
New +$62K ﹤0.01% 1725

Other funds holding TRPX

Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
APA
American Portfolios Advisors Holbrook, New York $2.36B AUM 14.59% 1-Year Est. Return

Oxford Asset Management's TRPX Position: Q1 2019 in Review

Oxford Asset Management sold out of Therapix Biosciences Ltd. (TRPX) in Q1 2019, closing a stake of 10,709 shares — an estimated $35K sold.

Oxford Asset Management first reported a position in TRPX in Q4 2018 and held it in 1 quarter. The position peaked at $35K in Q4 2018. 4 funds tracked by Wall St. Rank hold TRPX as of Q1 2019.

  • Oxford Asset Management reported no remaining Therapix Biosciences Ltd. position as of Q1 2019 after selling out during the quarter.
  • Oxford Asset Management sold 10,709 Therapix Biosciences Ltd. shares in Q1 2019, an estimated $35K.
  • Oxford Asset Management first reported a position in Therapix Biosciences Ltd. in Q4 2018 and held it in 1 quarter.
  • Oxford Asset Management's Therapix Biosciences Ltd. position peaked at $35K in Q4 2018.
  • 4 funds tracked by Wall St. Rank held Therapix Biosciences Ltd. as of Q1 2019.

Based on Oxford Asset Management's 13F filing for Q1 2019, filed 15 May 2019.